BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

SOLEXA TO HOLD SECOND QUARTER 2006 FINANCIAL RESULTS CONFERENCE CALL ON AUGUST 14

HAYWARD, Calif. (August 2 2006) – Solexa, Inc. (Nasdaq: SLXA) today announced that it will release financial results for the second quarter of 2006 after market close on Monday, August 14, 2006. Solexa management will host an investment-community conference call at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss those results and answer questions. 

Individuals interested in participating in the conference call may do so by dialing (800) 218-8862 for domestic callers or (303) 262-2130 for international callers. Those interested in listening to the conference call live via the Internet may do so by visiting the Investors section of the Company's Web site at www.solexa.com. 

A webcast replay will be available on the Solexa Web site. A telephone replay will be available for 48 hours following the conclusion of the call by dialing (800) 405-2236 for domestic callers, or (303) 590-3000 for international callers, and entering pass code 11067697#.

- ENDS -

About Solexa

Solexa, Inc. is developing and commercializing the Solexa Genome Analysis System, which will be used to perform a range of analyses including whole genome resequencing, gene expression analysis and small RNA analysis. Solexa expects its first-generation instrument, the 1G Genome Analyzer, to generate over a billion bases of DNA sequence per run and to enable human genome resequencing below $100,000 per sample, making it the first platform to reach this important milestone. Solexa's longer-term goal is to reduce the cost of human re-sequencing to a few thousand dollars for use in a wide range of applications from basic research through clinical diagnostics. For further information, please visit www.solexa.com.  

For more information, please contact:  

European Media Contact:

Northbank Communications

Sue Charles, CEO s.charles@northbankcommunications.com  

Lorna Watson, Senior Account Manager l.watson@northbankcommunications.com

+44 (0)20 7886 8150 

Investor Contacts:

EVC Group, Inc.

Doug Sherk ( dsherk@evcgroup.com )

Jenifer Kirtland (jkirtland@evcgroup.com)

(415) 896-6820

North American Media Contact:

EVC Group, Inc

Steve DiMattia

646-277-8706

sdimattia@evcgroup.com

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.